Published in

Taylor and Francis Group, Leukemia & Lymphoma, 13(61), p. 3146-3153, 2020

DOI: 10.1080/10428194.2020.1805109

Links

Tools

Export citation

Search in Google Scholar

Updated safety of midostaurin plus chemotherapy in newly diagnosed FLT3 mutation–positive acute myeloid leukemia: the RADIUS-X expanded access program

Journal article published in 2020 by Gail J. Roboz, Stephen A. Strickland ORCID, Mark R. Litzow ORCID, Andrew Dalovisio, Alexander E. Perl ORCID, Gaetano Bonifacio, Kelly Haines, Alysha Barbera, Das Purkayastha, Kendra Sweet
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO